| |
| |
|
| Insider
Information: |
Moore Nicholas G |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
38,520 |
|
|
Indirect Shares
|
32,261 |
|
|
| Direct
Value |
$2,369,178 |
|
|
|
Indirect Value
|
$34,102 |
|
|
| Total
Shares |
70,781 |
|
|
| Total
Value |
$2,403,280 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Netapp Inc |
NTAP |
Director |
2014-09-05 |
15,188 |
2014-02-19 |
0 |
Premium* |
|
|
Gilead Sciences Inc |
GILD |
Director |
2018-03-01 |
12,233 |
2014-07-28 |
0 |
Premium* |
|
|
Hudson Global Inc |
HSON |
Director |
2005-08-04 |
0 |
2006-04-17 |
3,190 |
Premium* |
|
|
Wells Fargo & Co |
WFC |
Director |
2006-04-25 |
499 |
2006-04-25 |
500 |
Premium* |
|
|
E2open Inc |
EOPN |
Director |
2014-08-13 |
10,600 |
2014-08-13 |
28,571 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
178 |
12,233 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2017-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
173 |
12,055 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2016-11-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,406 |
11,882 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2016-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
169 |
15,288 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2015-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
167 |
15,119 |
0 |
- |
|
| NTAP |
Netapp Inc |
Director |
– • – |
2014-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,332 |
15,188 |
0 |
- |
|
| NTAP |
Netapp Inc |
Director |
– • – |
2014-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,856 |
2,856 |
0 |
- |
|
| EOPN |
E2open Inc |
Director |
– • – |
2014-08-13 |
4 |
OE |
$0.35 |
$234,046 |
D/D |
54,998 |
28,600 |
0 |
- |
|
| EOPN |
E2open Inc |
Director |
– • – |
2014-08-13 |
4 |
S |
$15.46 |
$850,506 |
D/D |
(54,998) |
10,600 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2014-07-28 |
4 |
S |
$90.56 |
$4,075,403 |
I/I |
(45,000) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2014-07-28 |
4 |
OE |
$26.62 |
$1,197,675 |
I/I |
45,000 |
45,000 |
0 |
- |
|
| EOPN |
E2open Inc |
Director |
– • – |
2014-06-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,600 |
10,600 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2014-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
167 |
14,952 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2014-02-26 |
4 |
S |
$84.05 |
$1,681,070 |
I/I |
(20,000) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2014-02-26 |
4 |
OE |
$26.62 |
$532,300 |
I/I |
20,000 |
20,000 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2014-02-19 |
4 |
OE |
$22.02 |
$419,782 |
I/I |
19,068 |
19,068 |
0 |
- |
|
| NTAP |
Netapp Inc |
Director |
– • – |
2014-02-19 |
4 |
OE |
$25.08 |
$1,390,900 |
I/I |
50,000 |
50,000 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2014-02-19 |
4 |
S |
$82.89 |
$1,584,990 |
I/I |
(19,068) |
0 |
0 |
- |
|
| NTAP |
Netapp Inc |
Director |
– • – |
2014-02-19 |
4 |
S |
$40.63 |
$2,031,655 |
I/I |
(50,000) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2013-08-30 |
4 |
AS |
$60.40 |
$9,166,583 |
I/I |
(151,720) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2013-08-30 |
4 |
OE |
$19.63 |
$3,118,014 |
I/I |
151,720 |
151,720 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2013-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
167 |
14,785 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2012-11-30 |
4 |
S |
$74.96 |
$4,872,550 |
D/D |
(65,000) |
7,309 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
– • – |
2012-11-30 |
4 |
OE |
$28.68 |
$1,863,875 |
D/D |
65,000 |
72,309 |
0 |
- |
|
| EOPN |
E2open Inc |
Director |
– • – |
2012-07-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
28,571 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
